These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 80223)

  • 1. Carcinoembryonic antigen in hepatocellular cancer.
    Macnab GM; Urbanowicz JM; Kew MC
    Br J Cancer; 1978 Jul; 38(1):51-4. PubMed ID: 80223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoembryonic antigen (CEA) in patients with malignant and non-malignant diseases.
    Alsabti EA; Kamel A
    Neoplasma; 1979; 26(5):603-9. PubMed ID: 230422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma.
    Hirohashi S; Shimosato Y; Ino Y; Kishi K; Ohkura H; Mukojima T
    Jpn J Clin Oncol; 1983 Mar; 13(1):37-43. PubMed ID: 6187946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do CA 19-9 and TPA play a minor role as compared to AFP in diagnosing primary hepatocellular carcinoma?
    Leandro G; Zizzari S; Fabris C; Basso D; Elba S; Del Favero G; Meggiato T; Angonese C; Di Mario F; Manghisi OG
    Oncology; 1989; 46(6):381-5. PubMed ID: 2479897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma carcinoembryonic antigen in the diagnosis and management of patients with hepatocellular carcinoma.
    Melia WM; Johnson PJ; Carter S; Munro-Neville A; Williams R
    Cancer; 1981 Aug; 48(4):1004-8. PubMed ID: 6168358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AFP, CEA, CA 19-9 and TPA in hepatocellular carcinoma.
    Maussier ML; Valenza V; Schinco G; Galli G
    Int J Biol Markers; 1990; 5(3):121-6. PubMed ID: 1704905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assay of the carcinoembryonic antigen (CEA) in acute and chronic liver diseases and hepatocellular carcinoma].
    Piantino P; Gallo V; Pecchio F; Garlanda PF; Bonardi O
    Minerva Med; 1981 Apr; 72(17):1059-64. PubMed ID: 6262678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation of tumour marker proteins in the diagnosis of primary hepatocellular carcinoma.
    Oon CJ; Yo SL; Chio LF; Chua D; Tan YO
    Ann Acad Med Singap; 1980 Apr; 9(2):228-33. PubMed ID: 6158907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha fetoprotein and carcinoembryonic antigen producing hepatocellular carcinoma. A case report studied by immunohistochemistry.
    Amano S; Kataoka H; Hazama F; Nakatake M; Maki A
    Acta Pathol Jpn; 1985 Jul; 35(4):969-74. PubMed ID: 2416187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of the determination of carcinoembryonic antigen (CEA) in benign and tumoral digestive pathology, chronic hepathopathies and hepatomas: study of 190 cases].
    Escudero Navarro JM; Rodrigo Saez L; Morcillo Herrera L; Faedo Presa I; Cornago Sánchez A; Pérez Alvarez R; García Saavedra L
    Rev Esp Enferm Apar Dig; 1980 Sep; 58(3):267-74. PubMed ID: 6256829
    [No Abstract]   [Full Text] [Related]  

  • 11. Carcinoembryonic antigen in liver disease.
    Richart C; Ruibal A; Monné J; Vilaseca J; Guardia J
    Lancet; 1979 Feb; 1(8113):447-8. PubMed ID: 84303
    [No Abstract]   [Full Text] [Related]  

  • 12. [A study of tumor markers in hepatocellular carcinoma].
    Nakayama T; Nishioka S; Matsunaga S; Oku A; Yataka I
    Nihon Shokakibyo Gakkai Zasshi; 1984 Nov; 81(11):2816-20. PubMed ID: 6084089
    [No Abstract]   [Full Text] [Related]  

  • 13. Carcinoembryonic antigen and lectin binding in the bile canalicular structures of hepatocellular carcinoma.
    Machinami R; Oono Y
    Virchows Arch A Pathol Anat Histopathol; 1987; 412(2):111-8. PubMed ID: 2827370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical evaluation of serum alpha-1-antichymotrypsin levels in liver disease and cancers.
    Matsuzaki S; Iwamura K; Itakura M; Kamiguchi H; Katsunuma T
    Gastroenterol Jpn; 1981 Dec; 16(6):582-91. PubMed ID: 6174385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-fetoprotein and carcinoembryonic antigen in patients with primary liver carcinoma, metastatic liver disease, and alcoholic liver disease.
    Bell H
    Scand J Gastroenterol; 1982 Oct; 17(7):897-903. PubMed ID: 6186010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study on tissue polypeptide antigen (TPA) as a tumor marker].
    Kanauchi M; Sawai F; Saito T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K
    Gan No Rinsho; 1984 Mar; 30(3):265-71. PubMed ID: 6201629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of serum anti-p53 antibodies as a prognostic factor in Egyptian patients with hepatocellular carcinoma.
    Atta MM; el-Masry SA; Abdel-Hameed M; Baiomy HA; Ramadan NE
    Clin Biochem; 2008 Oct; 41(14-15):1131-9. PubMed ID: 18616935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoassay for carcinoembryonic antigen and alpha 1-fetoprotein in the qualitative evaluation of focal hepatic lesions in Japan.
    Aburano T; Tonami N; Tada A; Hisada K
    Eur J Nucl Med; 1980 Aug; 5(4):373-6. PubMed ID: 6156837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of serum concentrations of tissue polypeptide antigen in the diagnosis of hepatocellular carcinoma.
    Kew MC; Berger EL
    Cancer; 1986 Jul; 58(1):127-30. PubMed ID: 2423221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-fetoprotein, carcinoembryonic antigen and various biochemical tests in patients with tumorous and inflammatory liver diseases.
    Weber P; Weberová D; Martínek K
    Neoplasma; 1988; 35(5):605-13. PubMed ID: 2464143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.